Delivery Order SPE2DB24D1205-SPE2DB24FCTVJ

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract is not set aside and has a firm fixed price of $10,437.90, with a completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML medical supplies. The contract has a ceiling value of $19,017.65 and a completion date of September 22, 2023. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,294.13, is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product, with a potential value of $1,820.64 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a total ceiling value of $5,637.40. The contract has a performance period through June 13, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a ceiling value of $26,733.10 and is a firm fixed price delivery order. The contract has an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a potential value of $1,591.02 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to support military treatment programs and facilities. No set-aside designation was...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ENGERIX-B 20 MCG/ML VIALML. The contract has a completion date of February 14, 2024 and a potential value of $1,820.64. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not have any set-aside designation for this...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,052.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of ENGERIX-B, a hepatitis B vaccine. The contract is a firm-fixed-price delivery order, with a ceiling value of $1,328.48 and an ultimate completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTVJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. The contract has a firm fixed price of $2,081.84 and a completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support federal healthcare programs and military treatment facilities. The contract is not designated as a set-aside. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a wide range of pharmaceutical and medical products to government customers.

Generated 11/15/24, 9:11 AM